Journal de la science des matériaux et des nanomatériaux

Abstrait

Metal Nanoparticles with Atomically Chiral Lattices and Optical Activity

Zhifeng Huang

Chiral nanoparticles (CNPs) have recently evoked increasing interest in nanomaterial sciences and technology, mainly due to imposing the chirality on nanomaterials. Metal and semiconductor CNPs have been generally produced through the induction by chiral ligands. However, the coexistence of chiral ligands will unavoidably screen the contribution of CNPs to the chiral interactions with (chiral) molecules. Alternatively, my group recently devised a versatile method, glancing angle deposition (GLAD) with fast substrate rotation, to fabricate metal CNPs with no use of chiral ligands. Macroscopic shear forces, applied by the substrate rotation in clockwise and counterclockwise along with the translation of incident atoms, lead to the generation of chiral lattices at atomic scales in the right- handed and lefthanded, respectively, in the CNPs and at their surfaces. The inherent chiral lattices cause metal CNPs to have optical activity, denoting the differential interaction with left- and right- handed circularly polarized light. Unary CNPs deposited by GLAD, functioning as a chiral host, have been treated by galvanic replacement reactions and layer-bylayer GLAD to produce multi-principal element alloy CNPs whose constituent elements, composition, morphology, chirality, phase, and size are engineerable. The atomically chiral lattices at their surfaces give rise to enantiospecific adsorption of molecules and result in an enantioselective amplification of molecular optical activity, which is practically desired for sensitive detection of chiral molecules. Moreover, metal CNPs have served as asymmetric catalysts to, e.g., mediate photoinduced enantioselective cyclodimerization of 2- Anthracenecarboxylic Acid. These results provide an insight into applying metal CNPs to potential applications in the practically vital fields of bioimaging, bio-sensing, disease diagnosis, and chiral drug production.